27 results on '"Davis, John A."'
Search Results
2. Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis
3. The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial
4. 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
5. Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled study
6. Joint modeling of dropout and outcome in three pivotal clinical trials of schizophrenia
7. Imputation of response rates from means and standard deviations in schizophrenia
8. Means of suicide in psychiatric patients: Population-based data from Israel between 2001 and 2020
9. About the issue of including or excluding studies from China in systematic reviews
10. Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
11. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
12. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
13. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder
14. Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: A randomized double-blind study
15. A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder
16. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: A randomized five month study
17. POSITIVE SYMPTOMS RESPOND TO ADD-ON ASPIRIN IN SCHIZOPHRENIA PATIENTS WITH HIGH SERA CRP LEVELS: A POST-HOC ANALYSIS OF AN RCT
18. 15:30 METFORMIN FOR TREATMENT OF ATYPICAL ANTIPSYCHOTIC-INDUCED WEIGHT GAIN AND ENDOCRINOLOGICAL SIDE EFFECTS IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA: RESULTS FROM RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY
19. Poster #203 A RANDOMIZED CONTROLLED TRIAL OF ALLOPURINOL VS. PLACEBO ADDED ON TO ANTIPSYCHOTICSIN PATIENTS WITH SCHIZOPHRENIAOR SCHIZOAFFECTIVE DISORDER
20. 14:00 MULTIPLE-TREATMENTS META-ANALYSIS ON THE EFFICACY, ACCEPTABILITY AND TOLERABILITY OF 15 ANTIPSYCHOTICS DRUGS IN SCHIZOPHRENIA
21. Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers
22. Age of illness onset and schizophrenic symptomatology during an inpatient washout period
23. Depot versus oral maintenance in schizophrenia: A meta-analysis of mirrow-image studies
24. Psychiatric medication compares favorably to drugs used in internal medicine: A meta-analysis
25. Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment
26. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients
27. Platelet monoamine oxidase in schizophrenia: a meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.